Only 3 tumor-reactive circulating CD8 T cell lines showed responses, which were limited to two CTA (PLAC1 and ACTL8) overlapping peptide pools, reiterating the challenge of finding relevant breast cancer antigens (Figure 2G). Here, CD8A is linked to breast carcinoma.